Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women.
about
High frequency of Fredrickson's phenotypes IV and IIb in Brazilians infected by human immunodeficiency virusDietary intake and body composition in HIV-positive and -negative South African womenHaemorheologic and fibrinolytic activity in Nigerian HIV infected patients.Coronary artery disease and human immunodeficiency virus infection.Disorders of glucose metabolism in patients infected with human immunodeficiency virus.Anthropometry in the prediction of sleep disordered breathing in HIV-positive and HIV-negative menNutrition and HIV infection.Rosiglitazone-Mediated Effects on Skeletal Muscle Gene Expression Correlate with Improvements in Insulin Sensitivity in Individuals with HIV-Insulin ResistanceAntiretroviral therapies associated with lipoatrophy in HIV-infected womenFibrinolytic changes in pregnant women on highly active antiretroviral therapy.Epidemiology and management of antiretroviral-associated cardiovascular disease.Lack of an effect of protease inhibitor use on glucose tolerance during pregnancyIncreased adipose tissue in male and female estrogen receptor-alpha knockout mice.Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.The association between diet and physical activity on insulin resistance in the Women's Interagency HIV Study.Relationships among HIV infection, metabolic risk factors, and left ventricular structure and functionMetabolic syndrome risks of cardiovascular disease: differences between HIV-positive and HIV-negative?Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women.HIV infection and glycemic response to newly initiated diabetic medical therapy.Repositioning HIV protease inhibitors as cancer therapeuticsGenetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users.Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.Alterations in lipid kinetics in men with HIV-dyslipidemia.Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients.Endocrinopathies in HIV, AIDS and HAART.Exercise and vitamin E intake are independently associated with metabolic abnormalities in human immunodeficiency virus-positive subjects: a cross-sectional study.Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.Biochemical Manifestation of HIV Lipodystrophy Syndrome.Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients.
P2860
Q24814179-72D2A96A-7EB9-4476-96F4-B8D681AF9626Q33711577-BD9FAF3B-343F-404F-9849-C75BAA9650DBQ33918603-D536B224-824C-4D79-9DF0-B279D444FA49Q34052597-27A58D91-DD13-4C5E-9414-EE630AF718C3Q34092346-7EC7891C-7D88-4B8C-BFDC-C928198EAFF2Q34158338-CC000F48-B706-48EC-9695-D8471BE68466Q34564488-1C080EF2-8447-4A3D-AD7B-23D675A94B56Q34955658-428976A5-6B4A-438F-A343-A92A7808679DQ35097650-75A7109D-A3C8-498E-9B91-0FBE4B2FF121Q35222063-911BC7BF-CF69-4648-BE7F-A671B087DB9FQ35338096-9179B708-B21F-4F81-9271-3C8AC7EE2072Q35614719-3C639A3F-CF2D-46D3-848D-66A1755C0A64Q35823619-B61D4D0D-8A03-4157-B231-11B58DD661E6Q36158019-F30CDFB3-8AE6-4CDC-9EE1-E0156D5A1ED3Q36487277-021AA613-9E72-4D58-9F51-A39AA2801B3BQ37025613-36668401-2DF4-42E0-A111-27E7A3679389Q37153502-212D91E3-97E1-4628-ADAB-572F04D52F04Q37161855-B2306096-5F3E-4F6F-BE01-202BD10FB39CQ37178529-E7C85840-5A8C-4F6C-92D9-66ADABD4464DQ37192579-40849FAC-E3FB-4FF2-BBB8-EC1186FC8EB1Q37330834-E9604C70-0E1B-43D6-9398-47FAEB6DD0EBQ38105267-0156BC3E-C2B0-4983-A177-23848914B3F8Q43048603-E8277D34-C4CF-4487-9F6C-AAF3D26E280FQ43974789-86D2C199-56EA-49F1-8AED-126444A0D80DQ44440416-940F1D86-4A5C-4AAC-B19A-07914C1247D5Q44510170-5E11CA8C-3638-41C4-8C67-CE053C1A3231Q44738362-35DC9373-0762-4345-B448-35C30B18B250Q45249289-1BC03E22-85E5-4E03-AC07-7CFF0507D607Q45722983-FAE2B126-8537-4936-93B8-50D1FB8CE075Q45729264-CB99D330-0700-4341-823C-3C14AD2C57B8Q45800319-747ACB7E-05FB-40A9-BA15-3B38A53A2EB1Q46563275-9702D86F-7F96-432E-843D-1BA8B229D0BF
P2860
Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Fasting hyperinsulinemia and c ...... ficiency virus-infected women.
@en
Fasting hyperinsulinemia and c ...... ficiency virus-infected women.
@nl
type
label
Fasting hyperinsulinemia and c ...... ficiency virus-infected women.
@en
Fasting hyperinsulinemia and c ...... ficiency virus-infected women.
@nl
prefLabel
Fasting hyperinsulinemia and c ...... ficiency virus-infected women.
@en
Fasting hyperinsulinemia and c ...... ficiency virus-infected women.
@nl
P2093
P356
P1476
Fasting hyperinsulinemia and c ...... ficiency virus-infected women.
@en
P2093
P304
P356
10.1210/JC.84.6.1932
P407
P577
1999-06-01T00:00:00Z